Regenxbio Inc (RGNX) — Strategic Asset Allocation Index
Regenxbio Inc (RGNX) has a Strategic Asset Allocation Index of 17.2% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $27.84 Million) total $27.84 Million, measured against net assets of $161.45 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Regenxbio Inc Strategic Asset Allocation Index (2015–2024)
This chart shows how Regenxbio Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the index stands at 17.2%, representing strategic assets of $27.84 Million against net assets of $161.45 Million USD. Explore cash efficiency ratio of Regenxbio Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Regenxbio Inc (2015–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Regenxbio Inc from 2015 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see RGNX market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 3.9% | $10.18 Million | $- | $10.18 Million | $259.65 Million | ▼ -8.5 pp |
| 2023 | 12.5% | $38.87 Million | $- | $38.87 Million | $311.74 Million | ▼ -66.4 pp |
| 2022 | 78.9% | $407.36 Million | $206.80 Million | $200.56 Million | $516.20 Million | ▲ +2.2 pp |
| 2021 | 76.8% | $586.62 Million | $192.45 Million | $394.17 Million | $764.30 Million | ▲ +48.5 pp |
| 2020 | 28.2% | $106.54 Million | $56.47 Million | $50.08 Million | $377.75 Million | ▼ -3.5 pp |
| 2019 | 31.7% | $142.84 Million | $39.05 Million | $103.78 Million | $450.20 Million | ▼ -3.6 pp |
| 2018 | 35.3% | $179.52 Million | $28.70 Million | $150.82 Million | $508.85 Million | ▲ +19.1 pp |
| 2017 | 16.2% | $29.59 Million | $13.98 Million | $15.62 Million | $183.03 Million | ▼ -32.5 pp |
| 2016 | 48.7% | $78.74 Million | $9.32 Million | $69.41 Million | $161.74 Million | ▲ +1.1 pp |
| 2015 | 47.5% | $103.06 Million | $538.00K | $102.53 Million | $216.81 Million | — |